---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-026963"
form_type: "8-K"
ticker: "INFU"
cik: "0001337013"
company_name: "InfuSystem Holdings, Inc"
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T07:30:42.592659+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# InfuSystem reports record Q2 revenue of $31.7M (+17% YoY), net income $0.4M, raises FY guidance

## Summary
- Net revenue record $31.7M (+17% YoY); Patient Services $19.3M (+12%), Device Solutions $12.4M (+27%).
- Net income $0.4M ($0.02 diluted EPS) vs net loss -$0.2M (-$0.01) in Q2 2022.
- Adjusted EBITDA $5.8M (18.2% margin), up 4% YoY and 36% sequentially.
- FY 2023 guidance raised: revenue growth above prior 8-10% range; Adj EBITDA margin 17-18%.

## SEC filing metadata
- accession: 0001628280-23-026963
- form_type: 8-K
- ticker: INFU
- cik: 0001337013
- company_name: InfuSystem Holdings, Inc
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1337013/000162828023026963/0001628280-23-026963-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1337013/000162828023026963/infu-20230803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-026963
- JSON: https://secwatch.observer/filing/0001628280-23-026963.json
- Plain text: https://secwatch.observer/filing/0001628280-23-026963.txt

## Key facts
- Earnings Releases
  InfuSystem Holdings, Inc reported second quarter ended June 30, 2023 results: revenue $31.7 million, net income $0.4 million, or $0.02 per diluted share, EPS $0.02 per diluted share. Guidance raised.
  - Period: second quarter ended June 30, 2023
  - Revenue: $31.7 million
  - Net income: $0.4 million, or $0.02 per diluted share
  - EPS: $0.02 per diluted share
  - Guidance: raised
  - Result: reported results
  source text: InfuSystem Reports Second Quarter 2023 Financial Results Record Net Revenues of $31.7 million Representing 17% Growth From the Prior Year Rochester Hills, Michigan, August 3, 2023 – InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the second quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1337013/000162828023026963/0001628280-23-026963-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.